Advanced Clinical Molecular Diagnostics: Detection of Inherited Diseases
Advanced Clinical Molecular Diagnostics: Detection of Inherited Diseases
- Module: 2
- Lecture: 1
- Instructor: Professor Labiner
- Course Code: MLSC 4053
Learning Objectives
- Chromosomal Abnormalities: Describe chromosomal structural abnormalities and recognize large-scale abnormalities affecting chromosome number or structure.
- Detection Methods: Explain how methodologies such as karyotyping and Fluorescence In Situ Hybridization (FISH) are utilized by molecular laboratories to detect mutations ranging from large scale to fine detail.
- Single-Gene Mutations: Describe single-gene mutations and their phenotypic patterns across structural proteins, receptor proteins, enzymes, and cell growth factors.
- Molecular Strategies: Compare and contrast testing strategies for single-point mutations versus nucleotide repeat (triplet repeat) diseases.
- Inheritance Patterns: Describe Mendelian patterns of inheritance as illustrated via family pedigree diagrams.
- Case Study (Cystic Fibrosis): Review molecular diagnostic methods for genes with multiple mutation possibilities, specifically the CFTR gene.
Models of Disease Etiology
- Genetic: Categorized as inherited diseases.
- Environmental: Categorized as somatic mutations or influences.
- Multifactorial: A combination of polygenic factors and somatic/environmental influences.
- Chromosomal Abnormalities: Large-scale changes in chromosome number or structural integrity.
Family History and Pedigree Diagrams
- Symbols in Pedigree Diagrams: * Square (): Represents a male. * Circle (): Represents a female. * Affected Male/Female: Indicated by a filled/shaded symbol. * Deceased Person: Indicated by a diagonal slash through the symbol.
- Transmission Patterns revealed by Pedigrees: * Autosomal Dominant (AD): Typically appears in every generation. * Autosomal Recessive (AR): Often skips generations; affected individuals usually have carrier parents. * Sex-linked (X-linked recessive): Pattern showing inheritance through the X chromosome, often affecting males more frequently.
Mendelian and Molecular Transmission Patterns
- Single-Gene Disorders: Diseases caused by a single genetic mutation. These follow standard transmission patterns: Autosomal Recessive, Autosomal Dominant, and Sex-linked.
- Mendelian Inheritance Assumption: Prediction of transmission patterns relies on the assumption that the mutant allele follows Mendelian rules.
- Functional Characterization of Mutations: * Gain of Function: Mutations that result in a new or enhanced function; these typically display a dominant phenotype. * Loss of Function: Mutations that result in reduced or eliminated function; these typically display a recessive phenotype. * Dominant Negative Patterns: Observed when a loss of function mutation occurs in a protein that forms part of a multimeric complex, interfering with the function of the wild-type subunits.
Loss of Heterozygosity (LOH)
- Definition: LOH occurs when a somatic mutation or deletion affects the normal allele in a heterozygous individual, leaving only the mutant allele.
- Phenotypic Impact: Autosomal recessive mutations may result in an abnormal phenotype in a hemizygous state () if the normal allele is lost.
- Mechanism: LOH often results from somatic events such as deletions of the normal chromosomal segment.
Molecular Detection of Single Gene Disorders: Case Studies
Hemochromatosis Type I
- Pathophysiology: A condition characterized by the over-absorption of iron from dietary sources.
- Genetics: Caused by mutations in the HFE gene, which encodes a membrane iron transporter. The HFE protein product interacts with -microglobulin at the cell membrane.
- Major Mutations: * : The primary mutation associated with the disease. * and : Other common mutations.
- Detection Method (PCR-RFLP for ): * The mutation in Exon 4 creates a new recognition site for the restriction enzyme . * Digestion Fragments: Wild-type () yields specific bands, while the mutation () creates additional fragments. * Fragment sizes documented: , , , and .
- Clinical Presentation: Visible on a liver biopsy using Hemosiderin stains, categorized by levels: Normal, Slt (Slight), Mod (Moderate), and Mkd (Marked).
Factor V Leiden (R506Q)
- Pathophysiology: A thrombophilic state (hypercoagulable phenotype) caused by a mutation in the gene for coagulation factor V (FVL).
- Molecular Cause: A transition at position 506 (R506Q).
- Detection Methods: * PCR-RFLP: In Exon 10, the mutation destroys an existing restriction site. Expected band sizes include , , , and . * SSP-PCR (Sequence-Specific Primer PCR): Uses primers specific to the mutation. The longer primer ends on the mutated base (A), producing a larger amplicon of for the mutation versus for the normal allele. * INVADER Assay: A flap-probe-based assay. A mutation-specific probe (Mut probe) forms a complex that allows cleavage only if the mutation is present. Fluorescence in the plate well indicates a positive result.
- Thrombosis Risk Factors (Multipliers ()): * Oral Contraceptive (OC) usage: * FV Leiden, Heterozygous: * FV Leiden, Homozygous: * FV Leiden (Heterozygous) + OC: * FV Leiden (Homozygous) + OC: * Prothrombin 20210, Heterozygous: * Prothrombin 20210 (Heterozygous) + OC:
Cystic Fibrosis (CF)
- Epidemiology: Most common genetic disease in Caucasians.
- Inheritance: Autosomal recessive.
- Statistics: Approximately individuals are affected; are carriers.
- Gene Details: The CFTR gene was identified in 1989 on chromosome . It consists of exons and spans a total of .
- Mutational Diversity: Over unique mutations have been identified.
- Most Common Mutation: .
Pharmacogenomics and Cytochrome P-450
- Cytochrome P-450 Polymorphisms: These are drug-metabolizing enzymes. Genetic testing can predict how a patient will respond to or the effectiveness of certain pharmaceutical drugs. These polymorphisms can either inhibit or induce drug metabolism.
- Pharmacogenomics definition: The study of genetic variations in drug response using genomic data across many samples to provide a personalized medicine approach.
Complexities in Disease Expression
- Penetrance: The frequency with which a disease phenotype is expressed in individuals carrying the mutation.
- Incomplete Penetrance: A state where the mutation is present, but the individual displays no abnormal phenotype.
- Variable Expressivity: A situation where the same genetic mutation results in a varied range of phenotypic severity or characteristics.
- Genetic Heterogeneity: Different independent mutations leading to the same clinical phenotype. This is common in diseases with multiple genetic components.
Non-Mendelian Transmission Patterns
- Gonadal Mosaicism: A somatic mutation occurring within germ-line cells, meaning the mutation is present in gametes but not necessarily the parent's somatic tissue.
- Genomic Imprinting: Nucleotide or histone modifications (such as methylation of Cytosine residues) that silence a gene without changing the DNA sequence. This process occurs during egg or sperm production. * Uniparental Disomy/Deletion Effects: The phenotype depends on whether the maternal or paternal allele is lost. * Prader-Willi Syndrome: Caused by a regional deletion or mutation on the paternally inherited chromosome . * Angelman Syndrome: Caused by a regional deletion or mutation on the maternally inherited chromosome .
- Nucleotide Repeat Expansion: The disruption of gene function caused by an increase in allele size due to repeated triplet sequences.
- Mitochondrial Inheritance: Maternal inheritance of genes located within the mitochondria. * Homoplasmy: A state where all mitochondria in a cell are identical (either all normal or all mutant). * Heteroplasmy: A mix of normal and mutant mitochondria within a single cell. Disease severity depends on the ratio of mutant to normal mitochondria.
Genetic Testing Limitations and Ethical Concerns
- Methodological Gaps: Molecular analysis may miss intergenic mutations in splice sites or regulatory regions if only coding regions (exons) are sequenced.
- Focus on Phenotype: Therapeutic targets are often phenotypic rather than genetic.
- Ethics: Nonsymptomatic diagnosis (testing before symptoms appear) raises significant ethical questions regarding privacy and psychological impact.
- Multifactorial Nature: Most traits and diseases are multifactorial, making genetic-only analysis incomplete.
Summary Table: Single-Gene Disorders and Molecular Methods
| Disease | Type of Protein | Gene (Location) | Mutation Type | Molecular Methods |
|---|---|---|---|---|
| Sickle Cell Anemia | Structural (Hemoglobinopathy) | Hemoglobin beta () | Missense | Sequencing, PCR-RFLP |
| Marfan Syndrome | Structural (Connective tissue) | Fibrillin () | Missense | Sequencing, Linkage analysis |
| Muscular Dystrophy | Membrane-associated | Dystrophin, DMD () | Deletion | Southern blot RFLP, multiplex PCR, linkage |
| Familial Hypercholesteremia | Cell surface receptor | LDL receptor () | Deletions, point mutations | Probe amplification, sequencing |
| Vitamin D-resistant Rickets | Nutritional/Receptor | Vitamin D receptor () | Point mutations | Southern blot RFLP, sequencing |
| Neurofibromatosis type 1 | Cell growth regulator | Neurofibromin () | Missense, frameshift, splice site | Sequencing, linkage analysis |
| Neurofibromatosis type 2 | Cell growth regulator | Merlin, NF-2 () | Nonsense, frameshift, splice site | Linkage analysis |
| Li-Fraumeni syndrome (LFS) | Cancer predisposition | TP53 () | Missense | Sequencing, SSCP, DGGE |
| Alkaptonuria (Ochronosis) | Enzyme (Metabolic) | Homogentisic acid oxidase () | Missense, frameshift, splice site | cDNA sequencing, SSCP |
| Phenylketonuria (PKU) | Enzyme (Metabolic) | PAH () | Splice site, missense, deletions | Ligase chain reaction, direct sequencing |
| SCID | Immunodeficiency | Adenosine deaminase () | Point mutations | Direct sequencing, capillary electrophoresis |
Note on LFS: A significant proportion of Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like (LFL) kindred do not have demonstrable TP53 mutations.